Copertina

Drug‐Coated Balloons Versus Drug‐Eluting Stents in Small Vessel De Novo Coronary Artery Disease: A Systematic Review and Meta‐Analysis

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Fahad Raja Khan, Syed Alishan, Kamran Aslam, Imran Ali, Hidayat Ullah, Fazal Akbar
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Catheterization and Cardiovascular Interventions
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Implementing Intravascular Imaging–Guided Percutaneous Coronary Intervention: A Scoping Review Using the Consolidated Framework for Implementation Research
di: Fahad Raja Khan, et al.
Pubblicazione: (2026)

Drug‐Coated Balloon‐Based Versus Drug‐Eluting Stent‐Only Treatment for Large Vessel Coronary Artery Disease
di: Eun‐Seok Shin, et al.
Pubblicazione: (2025)

Critique on “Drug‐Coated Balloons Versus Drug‐Eluting Stents in Small Vessel De Novo Coronary Artery Disease: A Systematic Review and Meta‐Analysis”
di: Richard G. Bogle, et al.
Pubblicazione: (2026)

Response to “Three‐Cusp View Orientation in TAVI: LOA Versus Non‐LOA—Translating Anatomical Alignment Into Functional Coronary Access”
di: Syed Alishan, et al.
Pubblicazione: (2025)

Comparative Outcomes of Drug‐Eluting Balloons Versus Drug‐Eluting Stents in Patients With Diabetes Undergoing PPCI
di: Hassan Shabeer, et al.
Pubblicazione: (2025)

A Comparison of a Drug Coated Balloon With Drug Eluting Stent Strategy for Treating Coronary Bifurcation Lesions
di: Natasha Corballis, et al.
Pubblicazione: (2025)

“Novel Non‐Hyperemic Coronary Physiology Indices for Vessel Longitudinal Analysis”
di: Fahad Raja Khan, et al.
Pubblicazione: (2025)

Cardiovascular Outcomes of Drug‐Coated Balloon Versus Drug‐Eluting Stents for Femoropopliteal Peripheral Arterial Disease Interventions: A Meta‐Regression Analysis
di: Yasar Sattar, et al.
Pubblicazione: (2026)

Drug‐Coated Balloons Versus Drug‐Eluting Stents for De Novo Ostial Left Circumflex Lesions: The International Multicenter DCB‐CIRCO Registry
di: Francesco Tartaglia, et al.
Pubblicazione: (2025)

Drug‐Coated Balloon‐Based Versus Drug‐Eluting Stent‐Only Treatment for Patients With High‐Bleeding Risk
di: Eun‐Seok Shin, et al.
Pubblicazione: (2026)

Rotational Atherectomy Followed by Modified (Cutting or Scoring) Balloon Versus Plain Balloon Before Drug‑Eluting Stent Implantation for Calcified Coronary Lesions: A Meta‐Analysis
di: Basma Badrawy Khalefa, et al.
Pubblicazione: (2025)

“Mid‐Term Efficacy and Safety of Mechanical Circulatory Support in High‐Risk Elective Chronic Total Occlusion Percutaneous Coronary Intervention: A Prospective Propensity‐Matched Cohort Study”
di: Fahad Raja Khan, et al.
Pubblicazione: (2025)

Comparison of Oxidative Stress Effects Between Drug‐Eluting Stents and Drug‐Coated Balloons: Insights Into Vascular Response and Clinical Implications
di: Muzaffer Aslan, et al.
Pubblicazione: (2025)

Letter to the Editor: Response to “Differences in Coronary Alignment Between Evolut FX and Navitor Valves”
di: Fahad Raja Khan, et al.
Pubblicazione: (2025)

Stent Fracture of Biolimus‐Eluting Stent (Biofreedom) Complicated With Micro‐Coronary Artery Aneurysm
di: Kosuke Muto, et al.
Pubblicazione: (2025)

Scaffold Versus Repeat Drug‐Coated Balloon Therapy for Early and Late Drug‐Coated Balloon Restenosis in Femoropopliteal Arteries: Results of the RECURRENCE‐2 Study
di: Takashi Yanagiuchi, et al.
Pubblicazione: (2025)

Balloon Dilation Technique Influences Stent Shortening and Intentional Stent Fracture During Overexpansion of Drug‐Eluting Stents: A Bench‐Testing Study
di: Mudit Gupta, et al.
Pubblicazione: (2025)

Drug‐Coated Balloons in Coronary Artery Disease: Engineering, Pharmacology, and the Mechanisms Behind Angiographic Outcomes
di: Marcello Marchetta, et al.
Pubblicazione: (2026)

The First‐in‐Man Technique of Drug Eluting and Perfusion Therapy for Left Main Coronary Artery Disease
di: Takayuki Warisawa, et al.
Pubblicazione: (2025)

Comparing the Clinical Performance of Paclitaxel‐Coated Balloons and Paclitaxel‐Eluting Stent for Treating Long Femoropopliteal Artery Disease: Results of the CAPELLA Study
di: Naoki Yoshioka, et al.
Pubblicazione: (2025)

Drug‐Coated Balloons Versus Non‐Coated Balloons for Side Branch Treatment in Bifurcation Lesions: A Systematic Review and Meta‐Analysis
di: Matteo Rocchetti, et al.
Pubblicazione: (2025)

Long‐Term (5‐Years) Outcomes of Current Drug‐Eluting Stents in Percutaneous Coronary Intervention: A Network Meta‐Analysis of Randomized Controlled Trials
di: Aman Goyal, et al.
Pubblicazione: (2025)

Comparative Outcomes of Supera Interwoven Nitinol Versus Eluvia Fluoropolymer‐Based Drug‐Eluting Stents for the Treatment of Severely Calcified Femoropopliteal Artery Lesions: Results of the ELDORADO Study
di: Takashi Yanagiuchi, et al.
Pubblicazione: (2025)

Long‐Term Outcomes After Percutaneous Coronary Intervention With the Polymer‐Free Biolimus‐Coated BioFreedom Stent Versus the Biodegradable‐Polymer Sirolimus‐Eluting Orsiro Stent in Patients With Acute Coronary Syndromes
di: Manijeh Noori, et al.
Pubblicazione: (2026)

Paclitaxel‐Coated Balloon for the Management of In‐Stent Coronary Restenosis: An Updated Meta‐Analysis and Trial Sequential Analysis
di: Vinícius M. R. Oliveira, et al.
Pubblicazione: (2025)

One‐Year Outcomes of Short‐Term Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention With Drug‐Eluting Stents: A Meta‐Analysis of Randomized Clinical Trials
di: Thomas Fretz, et al.
Pubblicazione: (2025)

Physiologic Assessment Using Angiography‐Derived Fractional Flow Reserve After Drug‐Coated Balloon Angioplasty in De Novo Coronary Lesions
di: Chun‐Chin Chang, et al.
Pubblicazione: (2026)

Application of Drug‐Coated Balloons in Complex High Risk and Indicated Percutaneous Coronary Interventions
di: Yvemarie B. O. Somsen, et al.
Pubblicazione: (2024)

Long‐Term Clinical Impact of Successful Vessel Preparation in Femoropopliteal Drug‐Coated Balloon Angioplasty
di: Yusuke Tomoi, et al.
Pubblicazione: (2025)

Critique on “Paclitaxel‐Coated Balloon for the Management of In‐Stent Coronary Restenosis: An Updated Meta‐Analysis and Trial Sequential Analysis”
di: Emaan Sadiq
Pubblicazione: (2025)

Interaction Between Guiding‐Extension Catheter and Drug‐Eluting Stents: Always Safe or Sometimes Harmful?
di: Salvatore Colangelo, et al.
Pubblicazione: (2025)

Underlying Mechanisms of Second‐Generation Drug Eluting Stent Thrombosis: An Optical Coherence Tomography Study
di: Eser Durmaz, et al.
Pubblicazione: (2025)

Enhanced Drug Effect With Cutting Balloon Followed by Drug Coated Balloon in a Rabbit Model
di: Manabu Shiozaki, et al.
Pubblicazione: (2025)

Coronary Angiography‐Derived Murray Law‐Based Quantitative Flow Ratio (μQFR) After De Novo Drug‐Coated Balloon Angioplasty
di: Dorian Garin, et al.
Pubblicazione: (2025)

Efficacy and Safety of Sirolimus‐Coated Balloon Angioplasty in De Novo Lesions in Large Coronary Vessels: A Propensity Score‐Matched Study
di: Cecilia Gobbi, et al.
Pubblicazione: (2025)

Development and Internal Validation of a Four‐Predictor Nomogram for In‐Stent Restenosis After Drug‐Eluting Stent Implantation in Patients With Overweight/Obesity
di: Guo‐Biao Li, et al.
Pubblicazione: (2025)

Three‐Year Outcome of Drug Coated Balloon Angioplasty Following Atherectomy for Severely Calcified Coronary Lesions
di: Taka‐aki Takamura, et al.
Pubblicazione: (2025)

The Clinical Outcome of Drug‐Coated Balloon Following Jetstream and Drug‐Coated Balloon for Femoropopliteal Nodular Calcification Lesions: The Results of the Multicenter ORION Study
di: Kenji Ogata, et al.
Pubblicazione: (2026)

Drug‐Coated Balloons in Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From the PROGRESS‐CTO Registry
di: Deniz Mutlu, et al.
Pubblicazione: (2025)

Vascular Healing After Biodegradable Polymer Sirolimus‐Eluting Versus Durable Polymer Everolimus‐Eluting Stents in Chronic Total Occlusions
di: Geng Wang, et al.
Pubblicazione: (2025)